Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welmid 25 Capsules
Welmid 25 Capsules offer an advanced treatment option for multiple myeloma, myelodysplastic syndromes (MDS), and related blood disorders. With Lenalidomide 25mg, this trusted immunomodulatory therapy helps control disease progression, improve blood cell counts, and enhance overall patient outcomes.
Uses of Welmid 25 Capsules
Treatment of multiple myeloma, particularly in combination with other agents
Management of myelodysplastic syndromes (MDS) associated with 5q deletion
Effective in relapsed or refractory mantle cell lymphoma
Reduces tumor burden and supports normal blood cell production
Enhances the body’s immune response to fight abnormal cells
Benefits of Welmid 25 Capsules
Clinically proven to improve progression-free and overall survival in certain cancers
Modulates the immune system to target and destroy abnormal cells
Inhibits angiogenesis, preventing tumor growth and spread
Convenient oral dosing for easy administration at home
Widely trusted by oncologists and hematologists for its efficacy and safety profile
Mechanism of Action of Welmid 25 Capsules
Modulates immune activity, stimulating the immune system to recognize and attack cancer cells.
Inhibits blood vessel growth (angiogenesis) that tumors rely on for survival.
Directly affects tumor cells, reducing their growth and encouraging their death.
Supports the production of healthy blood cells, improving hematologic parameters and quality of life.